What Is RNF2 Antibody, and What Role Does RNF2 Play in Chromatin?

The RNF2 antibody targets RNF2 (Ring Finger Protein 2), also known as RING1B or RING2, a critical E3 ubiquitin ligase and catalytic core component of the Polycomb Repressive Complex 1 (PRC1). RNF2 antibody mediates the monoubiquitination of histone H2A at lysine 119 (H2AK119ub1) — an epigenetic mark tightly associated with transcriptional silencing and chromatin compaction. 

The study of RNF2 and its enzymatic activity sits at the intersection of chromatin biology, developmental gene regulation, and cancer epigenetics, making validated RNF2 antibodies essential reagents in multiple cutting-edge research fields.

Biological Function of RNF2

RNF2 forms a heterodimer with RING1A within the PRC1 complex to generate ubiquitin ligase activity. The resulting H2AK119ub1 modification is one of the most abundant histone ubiquitination marks in mammalian cells and plays multiple roles:

• Transcriptional repression: Silences developmental genes including HOX clusters to maintain cell identity

• DNA damage response: Participates in histone ubiquitination at double-strand break sites

• X chromosome inactivation: Contributes to the epigenetic silencing of the inactive X chromosome

• Stem cell maintenance: Required for proper embryonic stem cell differentiation and self-renewal

Beyond its canonical role in PRC1-mediated repression, RNF2 has also been implicated in the regulation of the 3D genome architecture. PRC1 complexes containing RNF2 contribute to the formation of Polycomb domains — topologically distinct chromatin compartments where developmentally silenced genes are spatially organized. This architectural function is independent of H2AK119ub1 activity and adds a layer of complexity to understanding how RNF2 modulates gene expression programs.

Research Applications of RNF2 Antibodies

Western Blot (WB)

RNF2 antibodies are validated for Western blot analysis to assess RNF2 protein expression levels across cell lines and experimental conditions. Expected molecular weight: ~37 kDa. Western blot is useful for studying PRC1 complex remodeling in response to differentiation signals, drug treatments, or genetic perturbations. Co-immunoprecipitation of RNF2 followed by Western blot detection allows identification of protein-protein interactions within the PRC1 complex.

ELISA

ELISA-format RNF2 detection is applicable in high-throughput settings for quantifying RNF2 levels across multiple samples simultaneously, particularly in drug discovery programs targeting epigenetic regulators. Quantitative comparison of RNF2 protein levels between treated and untreated cells enables dose-response characterization of PRC1-targeting compounds at the protein level.

Chromatin Immunoprecipitation (ChIP)

While specific antibody clones may be primarily validated for WB and ELISA, ChIP-grade RNF2 antibodies are used in the field to map PRC1 genomic occupancy — identifying Polycomb-regulated gene loci in normal and cancer cells. ChIP-seq with RNF2 antibodies generates genome-wide occupancy maps that reveal which developmental and tumor suppressor gene promoters are under active Polycomb control, providing mechanistic insight into how PRC1-driven silencing shapes cell identity and oncogenesis.

RNF2 in Disease and Cancer

Dysregulation of RNF2 and PRC1 function is implicated in multiple malignancies. In prostate cancer, RNF2 overexpression promotes tumor growth by silencing p16/INK4A and other tumor suppressors. In breast cancer, elevated RNF2 levels correlate with aggressive phenotypes and poor prognosis. In colorectal and gastric cancers, PRC1/RNF2 dysregulation contributes to epigenetic silencing of differentiation genes. RNF2 has therefore emerged as a candidate therapeutic target, and its accurate quantification by immunoassay is essential for evaluating EZH2/PRC1-targeting compounds in preclinical models. The availability of RNF2 as a measurable pharmacodynamic biomarker makes it particularly useful in clinical translation studies.

Selecting an RNF2 Antibody

Key validation parameters include specificity (confirm no cross-reactivity with RING1A, a structurally similar paralog), application validation to ensure performance in Western blot or ELISA matches experimental needs, species reactivity (human, mouse, and rat cross-reactivity should be tested), and verification of positive controls using HeLa cells or MCF-7 cells, both of which express detectable levels of RNF2 under standard culture conditions.

Conclusion

The RNF2 antibody is a powerful research tool for studying Polycomb-mediated epigenetic regulation, histone ubiquitination, and transcriptional silencing. Given RNF2's roles in stem cell biology, development, and cancer, validated antibodies that accurately detect this protein in Western blot and ELISA formats are essential reagents in chromatin biology and oncology research laboratories working at the frontier of epigenetic drug discovery and developmental gene regulation.